Brandes Investment Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.88M Buy
729,502
+37,877
+5% +$453K 0.07% 131
2026
Q1
$4.14M Buy
691,625
+85,126
+14% +$641K 0.03% 144
2025
Q4
$4.35M Buy
606,499
+193,064
+47% +$1.53M 0.03% 146
2025
Q3
$4.42M Buy
413,435
+15,012
+4% +$147K 0.04% 136
2025
Q2
$3.86M Buy
398,423
+173,481
+77% +$1.79M 0.03% 133
2025
Q1
$3.35M Buy
224,942
+14,419
+7% +$222K 0.03% 135
2024
Q4
$3.14M Sell
210,523
-1,264
-0.6% -$20.6K 0.04% 141
2024
Q3
$4.05M Buy
211,787
+7,065
+3% +$146K 0.05% 130
2024
Q2
$4.24M Buy
204,722
+11,051
+6% +$220K 0.05% 123
2024
Q1
$3.64M Buy
193,671
+15,135
+8% +$260K 0.05% 124
2023
Q4
$2.57M Buy
+178,536
New +$2.43M 0.04% 134
2021
Q4
Sell
-118,930
Closed -$3.9M 168
2021
Q3
$3.9M Buy
118,930
+2,946
+3% +$94.3K 0.08% 109
2021
Q2
$3.51M Buy
+115,984
New +$3.82M 0.08% 108

Other funds holding OGN

Brandes Investment Partners's OGN Position: Q2 2026 in Review

Brandes Investment Partners increased its Organon & Co (OGN) stake by 5.5% in Q2 2026, buying an estimated $453K and bringing the position to 729,502 shares worth $9.88M. The position accounts for 0.07% of the portfolio, ranked #131.

Brandes Investment Partners first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Brandes Investment Partners held 729,502 shares of Organon & Co worth $9.88M as of Q2 2026.
  • Brandes Investment Partners bought 37,877 Organon & Co shares in Q2 2026, an estimated $453K.
  • Organon & Co made up 0.07% of Brandes Investment Partners's portfolio in Q2 2026, its #131 holding.
  • Brandes Investment Partners first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Brandes Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.